Medical Science Liaison (MSL) - MRD, Southeast US/Florida

Medical Science Liaison (MSL) - Molecular Residual Disease

Location: US based: Southeast US/ FL

SAGA Diagnostics is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analysis of circulating tumor DNA (ctDNA). The company's mission is to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services. SAGA's proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at unprecedented sensitivity and scale.

The Medical Science Liaison (MSL) in Molecular Residual Disease (MRD) is a highly specialized role focused on advancing the scientific understanding and clinical application of MRD testing in oncology. MRD testing is used to detect the presence of molecular residual disease, which may indicate the persistence of cancer cells after treatment, potentially leading to relapse.

The MSL serves as a key scientific expert in this field, providing clinical and scientific support for MRD assays and solutions, fostering relationships with key opinion leaders (KOLs), clinicians, and researchers, and ensuring that MRD testing plays a pivotal role in the management of cancer patients.

As the MSL for Molecular Residual Disease, the successful candidate will play a critical role in shaping the clinical adoption and implementation of MRD testing in oncology. They will contribute to the broader mission of improving cancer patient care by offering cutting-edge diagnostic tools that enable earlier detection of disease recurrence and more precise treatment decisions.

Key Responsibilities:

1. Scientific Expertise and Communication:
• Act as the primary scientific resource and subject matter expert for molecular residual disease testing, its clinical utility, and application in oncology.
• Communicate and disseminate cutting-edge scientific information regarding MRD testing methods (e.g., PCR, NGS, flow cytometry) and their role in patient management, recurrence detection, and treatment decision-making.
• Provide scientific support to healthcare professionals, researchers, and clinical teams regarding the latest MRD-related research, product development, and applications in oncology.
2. KOL Engagement and Relationship Building:
• Identify, engage, and establish relationships with key opinion leaders (KOLs), oncologists, hematologists, and other stakeholders involved in MRD research and clinical practice.
• Present scientific data, research findings, and clinical evidence related to MRD assays to KOLs, driving discussions on the clinical utility of MRD testing in various cancer types.
• Coordinate advisory boards, scientific symposia, and research collaborations with KOLs to foster ongoing dialogue and knowledge sharing.
3. Clinical and Scientific Support:
• Provide insights to internal teams (e.g., product development, regulatory, marketing, sales) regarding MRD-related scientific data, clinical studies, and market needs.
• Interpret clinical trial data, real-world evidence, and research studies related to MRD and contribute to discussions around its clinical impact, including in early- and late-stage cancer care.
• Support the design of clinical studies and post-market surveillance to evaluate the effectiveness and application of MRD testing in different oncologic settings.
4. Training and Education:
• Deliver scientific presentations, educational workshops, and training sessions to internal teams, healthcare providers, and clinical partners on MRD testing and its role in cancer monitoring and treatment.
• Ensure that medical and sales teams are equipped with comprehensive, up-to-date knowledge on MRD assays, including their clinical benefits and limitations.
• Develop and review educational materials, including scientific publications, product briefs, and clinical guides, to enhance awareness and adoption of MRD testing.
5. Scientific Data Generation and Dissemination:
• Collaborate with research and clinical teams to design and implement studies that generate data to support the clinical value of MRD testing, including clinical trials, retrospective studies, and registries.
• Work with cross-functional teams to develop scientific content for publication in peer-reviewed journals, presentation at scientific conferences, and development of abstracts and posters.
• Contribute to the creation of evidence-based materials such as white papers, case studies, and real-world data to demonstrate the clinical relevance of MRD testing in cancer management.
6. Market Inte